EUVIMEDEUVIMED entdecken
Crossref

Interleukin-1 inhibits the synthesis of von Willebrand factor in endothelial cells, which results in a decreased reactivity of their matrix toward platelets.

P G de Groot, C L Verweij, P P Nawroth, H C de Boer, D M Stern, J J Sixma

Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · 1987-11 · 7 (6) · 605-611

DOI: 10.1161/01.atv.7.6.605 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1987-11. Verfasst von P G de Groot und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, University Hospital Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Platelet Adhesiveness. Die Arbeit wurde bisher 25-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We have studied the influence of recombinant human and murine interleukin-1 (IL-1) on the synthesis and secretion of von Willebrand factor by human endothelial cells. Treatment of endothelial cells with IL-1 caused a decline in the steady-state level of von Willebrand factor mRNA in endothelial cells. This decline resulted in a decreased secretion to the culture medium, a decreased storage of von Willebrand factor in the Weibel-Palade bodies, and a decreased incorporation into the extracellular matrix. As a consequence of the decreased amount of von Willebrand factor in the extracellular matrix we have found a strongly impaired platelet adhesion to these matrices. When the matrices of IL-1-treated cells were incubated with purified von Willebrand factor, their ability to support platelet adhesion was restored. These results suggest that perturbation of endothelial cells by inflammatory mediators like IL-1 results in a decreased adhesion of platelets to the subendothelium owing to a diminished synthesis of von Willebrand factor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet AdhesivenessCells, CulturedEndothelium, VascularEpoprostenolExtracellular MatrixHumansInterleukin-1von Willebrand Factor

Substanzen

Interleukin-1von Willebrand FactorEpoprostenol

Autor:innen und Institutionen

  • Department of Haematology, University Hospital Utrecht, The Netherlands.

Zitieren

APA

de Groot, P. G., Verweij, C. L., Nawroth, P. P., de Boer, H. C., Stern, D. M., & Sixma, J. J. (1987). Interleukin-1 inhibits the synthesis of von Willebrand factor in endothelial cells, which results in a decreased reactivity of their matrix toward platelets. Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 7(6), 605-611. https://doi.org/10.1161/01.atv.7.6.605

Vancouver

de Groot PG, Verweij CL, Nawroth PP, de Boer HC, Stern DM, Sixma JJ. Interleukin-1 inhibits the synthesis of von Willebrand factor in endothelial cells, which results in a decreased reactivity of their matrix toward platelets. Arteriosclerosis: An Official Journal of the American Heart Association, Inc.. 1987;7(6):605-611. doi:10.1161/01.atv.7.6.605

BibTeX
@article{deGroot1987,
  author = {de Groot, P G and Verweij, C L and Nawroth, P P and de Boer, H C and Stern, D M and Sixma, J J},
  title = {Interleukin-1 inhibits the synthesis of von Willebrand factor in endothelial cells, which results in a decreased reactivity of their matrix toward platelets},
  journal = {Arteriosclerosis: An Official Journal of the American Heart Association, Inc.},
  year = {1987},
  volume = {7},
  number = {6},
  pages = {605--611},
  doi = {10.1161/01.atv.7.6.605}
}
Kostenlos starten →